Agq Labs Usa company information, Employees & Contact Information

Consumer confidence dips as markets rally The Real Economy Blog

Prolonged Attachment of Rhipicephalus microplus Tick Without Systemic Manifestations: A Case Report Cureus

Everest stock drops 11% following AIG deal announcement and Q3 earnings Insurance Insider US

Chrysler Faces Class Action Lawsuit Over Key Programmer Theft Claims Motorious

EY US - Home | Building a better working world EY

Driving change: The new roadmap for automotive retail transformation RSM

Daily Digest: Top news from October 28 Insurance Insider US

Massive Nationwide Cancer Charity Fraud Scheme Serves as Warning Oncology News Central

American Rheinmetall Munitions and Solugen to formalize partnership Rheinmetall

California proposes regs requiring insurers to report climate, AI risk scenarios Insurance Insider US

Holly Starks Acquires the Flumberico Brand, Expanding the Vision Behind flumberico.us.com Yahoo Finance

AdvaMed Code of Ethics® AdvaMed® - Advanced Medical Technology Association®

FLUMIST® (Influenza, Vaccine Live, Intranasal), the nation’s only nasal spray flu vaccine, now available for home delivery AstraZeneca US

BofA Launches ‘Golf with Us’ to Bring Affordable Rounds to More Than 50,000 Youth Nationwide Bank of America

Car donation charity fined millions, accepts fundraising restrictions in Colorado and 18 other states CBS News

U.S.A. Home Hitachi Global

FM appoints Liberty Mutual’s Erbig as new CFO Insurance Insider US

Empowering Action in Asthma Care This Season and Beyond AstraZeneca US

iPR Pharmaceuticals Earns its 1st EPA’s ENERGY STAR® Certification for Superior Energy Efficiency AstraZeneca US

AstraZeneca impact in the US AstraZeneca US

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer AstraZeneca US

Our impact, our people AstraZeneca US

AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D AstraZeneca US

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial AstraZeneca US

AIRSUPRA ® (albuterol/budesonide) US prescribing information updated to reflect the statistically significant severe exacerbation risk reduction in patients with mild asthma compared with albuterol AstraZeneca US

Delaware AG joins lawsuit against 'deceptive' breast cancer fundraising operation The News Journal

Nationwide Fake Cancer Charity Scam Busted, Kars-R-Us.com Inc. Accused Hoodline

Congress nullifies IRS crypto reporting regulations for DeFi platforms RSM

Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma AstraZeneca US

Partnerships in Motion: How Cross-Sector Collaboration is Powering Broader Clinical Trial Representation AstraZeneca US

AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trial AstraZeneca US

Eneboparatide met primary endpoint of normalizing serum calcium in adults with hypoparathyroidism at 24 weeks in CALYPSO Phase III trial AstraZeneca US

American Rheinmetall secures order for T-158 tracks Rheinmetall

Rheinmetall completes acquisition of Loc Performance in the USA Rheinmetall

Announcing the 2024-2025 US ACT on Health Equity Community Investments Recipients AstraZeneca US

Collective Action to Advance Health Equity AstraZeneca US

Affordability AstraZeneca US

FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis AstraZeneca US

What science can do AstraZeneca US

AIRSUPRA (PT027) approved in the US for asthma AstraZeneca US

Announcing the 2023 Power of Us Award winners AstraZeneca US

Scot Anderson Womble Bond Dickinson

The Real Economy: October 2025 RSM

TAGRISSO® (osimertinib) granted Priority Review in the US for patients with unresectable, Stage III EGFR-mutated lung cancer AstraZeneca US

Tracy A. Bacigalupo Womble Bond Dickinson

Emergency Medicine: How Hospitals can Prepare for Life-threatening Bleeding AstraZeneca US

Careers AstraZeneca US

Investigator Sponsored Studies (ISS) Program Novo Nordisk U.S. Website

Rewards and benefits RSM

TEZSPIRE approved for self-administration in the US with a new pre-filled pen AstraZeneca US

Who We Are Otsuka US

Contact Us AstraZeneca US

AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA Phase III trial AstraZeneca US

FluMist approved for self-administration in the US AstraZeneca US

WAINUA (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis AstraZeneca US

Product patents Novo Nordisk U.S. Website

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH AstraZeneca US

ispace - U.S. Announces new U.S. Headquarters, Unveils APEX 1.0 Lunar Lander, Provides Updates on Mission 3 ispace

TAGRISSO® (osimertinib) approved in the US for patients with unresectable, Stage III EGFR-mutated lung cancer AstraZeneca US

Alexander P. Wharton Womble Bond Dickinson

Athletes Team USA

Capivasertib in combination with FASLODEX® (fulvestrant) granted Priority Review in the US for patients with advanced HR-positive breast cancer AstraZeneca US

FARXIGA extended in the US to reduce risk of cardiovascular death and hospitalization for heart failure to a broader range of patients AstraZeneca US

Portraits of Lung Cancer AstraZeneca US

SAPHNELO (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus AstraZeneca US

BYDUREON BCise (exenatide extended-release) approved in the US for the treatment of type 2 diabetes in pediatric patients ages 10 years and older AstraZeneca US

Agreement to takeover US vehicle specialist Loc Performance Rheinmetall

Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma AstraZeneca US

AstraZeneca’s Aradhana Sarin Named to CNBC’s 2024 Changemakers: Women Transforming Business List AstraZeneca US

Improving access and affordability Novo Nordisk U.S. Website

Personified: Bridget Therriault AstraZeneca US

LOKELMA® granted Fast Track Designation in the US to reduce cardiovascular outcomes in patients on chronic hemodialysis with hyperkalemia AstraZeneca US

AstraZeneca shares progress on LYNPARZA™ (olaparib) tablets in the US AstraZeneca US

US FDA approves new easy-to-use, once-weekly BYDUREON® BCise™ injectable medicine for patients with type-2 diabetes AstraZeneca US

Taking the Wheel in Diverse Clinical Trial Recruitment: Introducing AZ's AIRE Mobile Unit AstraZeneca US

AstraZeneca in the United States AstraZeneca US

Product Disposal Novo Nordisk U.S. Website

CALQUENCE plus obinutuzumab demonstrated sustained survival benefit in 1st-line chronic lymphocytic leukemia with 90% of patients surviving five years in ELEVATE-TN trial AstraZeneca US

ENHERTU® (fam-trastuzumab deruxtecan-nxki) significantly improved both progression-free and overall survival in DESTINY-Breast04 trial in patients with HER2-low metastatic breast cancer AstraZeneca US

ispace-U.S. to use Swedish Space Corporation’s Lunar Ground Station Network for its M3 Lunar Mission ispace

Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know AstraZeneca US

Unaccompanied Child Migrants in U.S. Communities, Immigration Court, and Schools migrationpolicy.org

Diabetes Pen Needles Novo Nordisk U.S. Website

FASLODEX® (fulvestrant) receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib AstraZeneca US

AstraZeneca US and Health Equity: Today & Tomorrow AstraZeneca US

Bart LaCount Appointed Chief Marketing Officer and Matt Rubin Appointed Chief Digital Officer of Popeyes® U.S. & Canada Popeyes Newsroom

AstraZeneca purchases US manufacturing facility to support biologics manufacturing capabilities AstraZeneca US

ULTOMIRIS® (ravulizumab-cwvz) approved in the US for adults with generalized myasthenia gravis AstraZeneca US

Meet our 2022 Power of Us Award Winners AstraZeneca US

The truth behind the ‘He Gets Us’ ads for Jesus airing during the Super Bowl CNN

Jonathan Reid Reich Womble Bond Dickinson

Employees Making an Impact in Their Communities AstraZeneca US

Grants & corporate giving Novo Nordisk U.S. Website

National High Potassium Awareness Day: Spreading the Word About High Potassium AstraZeneca US

US FDA approves SYMBICORT for the treatment of asthma in pediatric patients AstraZeneca US

BEVESPI AEROSPHERE™ approved by the US FDA for patients with COPD AstraZeneca US

US FDA approves TAGRISSO® (osimertinib) blood-based T790M companion diagnostic test AstraZeneca US

Cordia Reveals Updated Brand Identity and Launches Cordia-US.com PR Newswire

A Year’s Worth of Giving: Our 2017 Power of Us Impact AstraZeneca US

Explore DAZN | DAZN US DAZN